Ameritas Investment Partners’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1K Hold
2,819
﹤0.01% 2510
2026
Q1
$26K Hold
2,819
﹤0.01% 2475
2025
Q4
$20.9K Hold
2,819
﹤0.01% 2614
2025
Q3
$19.1K Hold
2,819
﹤0.01% 2683
2025
Q2
$19.5K Hold
2,819
﹤0.01% 2671
2025
Q1
$20.5K Hold
2,819
﹤0.01% 2544
2024
Q4
$22.6K Hold
2,819
﹤0.01% 2579
2024
Q3
$20.7K Hold
2,819
﹤0.01% 2642
2024
Q2
$18.5K Hold
2,819
﹤0.01% 2658
2024
Q1
$26.6K Hold
2,819
﹤0.01% 2448
2023
Q4
$22.1K Hold
2,819
﹤0.01% 2544
2023
Q3
$19K Hold
2,819
﹤0.01% 2564
2023
Q2
$27.6K Buy
+2,819
New +$28.6K ﹤0.01% 2386
2022
Q2
Sell
-3,037
Closed -$15K 3244
2022
Q1
$15K Hold
3,037
﹤0.01% 2673
2021
Q4
$16K Hold
3,037
﹤0.01% 2744
2021
Q3
$17K Hold
3,037
﹤0.01% 2782
2021
Q2
$22K Hold
3,037
﹤0.01% 2695
2021
Q1
$31K Hold
3,037
﹤0.01% 2363
2020
Q4
$24K Hold
3,037
﹤0.01% 2391
2020
Q3
$26K Hold
3,037
﹤0.01% 2246
2020
Q2
$29K Buy
+3,037
New +$23.6K ﹤0.01% 2154

Other funds holding VMD

Ameritas Investment Partners's VMD Position: Q2 2026 in Review

Ameritas Investment Partners held its Viemed Healthcare (VMD) position steady in Q2 2026 at 2,819 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2510.

Ameritas Investment Partners first reported a position in VMD in Q2 2020 and has held it in 21 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Ameritas Investment Partners held 2,819 shares of Viemed Healthcare worth $32.1K as of Q2 2026.
  • Ameritas Investment Partners left its Viemed Healthcare share count unchanged in Q2 2026.
  • Viemed Healthcare made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2510 holding.
  • Ameritas Investment Partners first reported a position in Viemed Healthcare in Q2 2020 and has held it in 21 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.